Joseph E Dinchuk

Title: Joseph E Dinchuk: Innovator in Chimeric Chemokine Receptors

Introduction

Joseph E Dinchuk is a notable inventor based in Stockton, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of chimeric chemokine receptors. His work has implications for various applications in medical research and drug development.

Latest Patents

Joseph E Dinchuk holds a patent for "Polynucleotides encoding chimeric chemokine receptors." This invention relates to a chimeric chemokine receptor that comprises two components. The first sequence includes the N terminus through the last residue of the seven helix transmembrane region of a first chemokine receptor. This is joined with a second sequence that comprises the C terminus of a second chemokine receptor, extending from the first intracellular residue to the last residue of the chemokine receptor. The chimeric chemokine receptor can be employed in various applications, such as ligand binding and screening assays, as well as signaling assays. Additionally, it can form a component of a chemokine receptor modulator design program. Joseph E Dinchuk has 1 patent to his name.

Career Highlights

Joseph E Dinchuk is associated with Bristol-Myers Squibb Company, where he has contributed to innovative research and development in the pharmaceutical industry. His work has been instrumental in advancing the understanding of chemokine receptors and their potential therapeutic applications.

Collaborations

Throughout his career, Joseph E Dinchuk has collaborated with esteemed colleagues, including Paul Davies and Qihong Zhao. These collaborations have further enriched his research and contributed to the advancement of the field.

Conclusion

Joseph E Dinchuk is a prominent inventor whose work on chimeric chemokine receptors has significant implications for medical research. His contributions continue to influence the development of innovative therapeutic strategies.